Smith & Nephew plc (LON:SN) Receives GBX 1,346.20 Average Target Price from Brokerages

Smith & Nephew plc (LON:SN) has received a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is GBX 1,346.20 ($16.91).

Several equities analysts have recently issued reports on SN shares. JPMorgan Chase & Co. upped their price objective on shares of Smith & Nephew from GBX 1,300 ($16.33) to GBX 1,381 ($17.35) and gave the company an “overweight” rating in a report on Thursday, May 2nd. Berenberg Bank restated a “buy” rating and set a GBX 1,450 ($18.22) price target on shares of Smith & Nephew in a research note on Thursday, May 2nd. Royal Bank of Canada reiterated an “outperform” rating and set a GBX 1,500 ($18.84) price objective on shares of Smith & Nephew in a research note on Tuesday. Jefferies Financial Group reissued a “buy” rating and issued a GBX 1,250 ($15.70) target price on shares of Smith & Nephew in a research report on Friday, May 3rd. Finally, Barclays reaffirmed an “equal weight” rating and set a GBX 1,150 ($14.45) price target on shares of Smith & Nephew in a research report on Friday, February 9th.

Smith & Nephew Trading Up 0.1 %

Shares of LON:SN opened at GBX 997.80 ($12.54) on Friday. The company has a debt-to-equity ratio of 59.11, a current ratio of 1.77 and a quick ratio of 0.84. The firm has a market capitalization of £8.72 billion, a P/E ratio of 4,153.33, a P/E/G ratio of 0.46 and a beta of 0.51. The business’s 50-day moving average is GBX 1,013.03 and its 200 day moving average is GBX 1,036.71. Smith & Nephew has a 1 year low of GBX 887 ($11.14) and a 1 year high of GBX 1,316.75 ($16.54).

Smith & Nephew Increases Dividend

The company also recently disclosed a dividend, which will be paid on Wednesday, May 22nd. Investors of record on Thursday, March 28th will be given a dividend of $0.23 per share. This is a boost from Smith & Nephew’s previous dividend of $0.14. This represents a yield of 1.62%. The ex-dividend date is Thursday, March 28th. Smith & Nephew’s dividend payout ratio (DPR) is presently 12,500.00%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.